Taniguchi Masahiko, Ptaszek Marcin, Chandrashaker Vanampally, Lindsey Jonathan S
Department of Chemistry, North Carolina State University, Raleigh, NC, 27695-8204, USA.
Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD, 21250-0001, USA.
Orig Life Evol Biosph. 2017 Mar;47(1):93-119. doi: 10.1007/s11084-016-9506-1. Epub 2016 May 20.
Attempts to develop a credible prebiotic route to tetrapyrroles have relied on enzyme-free recapitulation of the extant biosynthesis, but this process has foundered from the inability to form the pyrrole porphobilinogen (PBG) in good yield by self-condensation of the precursor δ-aminolevulinic acid (ALA). PBG undergoes robust oligomerization in aqueous solution to give uroporphyrinogen (4 isomers) in good yield. ALA, PBG, and uroporphyrinogen III are universal precursors to all known tetrapyrrole macrocycles. The enzymic formation of PBG entails carbon-carbon bond formation between the less stable enolate/enamine of one ALA molecule (3-position) and the carbonyl/imine (4-position) of the second ALA molecule; without enzymes, the first ALA reacts at the more stable enolate/enamine (5-position) and gives the pyrrole pseudo-PBG. pseudo-PBG cannot self-condense, yet has one open α-pyrrole position and is proposed to be a terminator of oligopyrromethane chain-growth from PBG. Here, 23 analogues of ALA have been subjected to density functional theoretical (DFT) calculations, but no motif has been identified that directs reaction at the 3-position. Deuteriation experiments suggested 5-(phosphonooxy)levulinic acid would react preferentially at the 3- versus 5-position, but a hybrid condensation with ALA gave no observable uroporphyrin. The results suggest efforts toward a biomimetic, enzyme-free route to tetrapyrroles from ALA should turn away from structure-directed reactions and focus on catalysts that orient the two aminoketones to form PBG in a kinetically controlled process, thereby avoiding formation of pseudo-PBG.
尝试开发一条可信的通向四吡咯的益生元途径,一直依赖于对现有生物合成过程进行无酶重现,但这一过程因无法通过前体δ-氨基乙酰丙酸(ALA)的自缩合以良好产率形成吡咯胆色素原(PBG)而受阻。PBG在水溶液中能强劲地寡聚化,以良好产率生成尿卟啉原(4种异构体)。ALA、PBG和尿卟啉原III是所有已知四吡咯大环的通用前体。PBG的酶促形成需要一个ALA分子较不稳定的烯醇化物/烯胺(3位)与第二个ALA分子的羰基/亚胺(4位)之间形成碳-碳键;没有酶时,第一个ALA会在较稳定的烯醇化物/烯胺(5位)发生反应,生成吡咯假PBG。假PBG不能自缩合,但有一个开放的α-吡咯位置,被认为是PBG寡聚吡咯甲烷链增长的终止剂。在此,对23种ALA类似物进行了密度泛函理论(DFT)计算,但未发现能引导在3位发生反应的基序。氘代实验表明5-(膦酰氧基)乙酰丙酸在3位与5位相比会优先发生反应,但与ALA的混合缩合未产生可观察到的尿卟啉。结果表明,从ALA出发构建一条仿生、无酶的四吡咯合成途径的努力,应摒弃结构导向反应,转而关注能在动力学控制过程中使两个氨基酮定向以形成PBG的催化剂,从而避免假PBG的形成。